MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NYSE:OPK) (“OPKO” or the “Company”) announces that Novitas Solutions has issued a draft local coverage determination for the 4Kscore® Test, the only blood test that accurately identifies an individual patient’s risk for high-grade, aggressive prostate cancer. Novitas Solutions is a Medicare Administrative Contractor (MAC) for Medicare jurisdictions L and H, with responsibility for nearly 10 million Medicare beneficiaries in New […]
Search Results for: hair test
4Kscore Test Results Significantly Influenced Physician-Patient Shared Decision-Making in Clinical Practice and Led to a 64.6% Reduction in Prostate Biopsies MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NYSE: OPK) announced today the results of a study for the 4Kscore® Test’s clinical utility in reducing the number of prostate biopsies performed, while increasing the probability of detecting aggressive prostate cancer […]
MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NYSE:OPK) announced today that the American Medical Association (AMA) Current Procedural Terminology (CPT®) Editorial Panel has granted a Category I CPT code for its 4Kscore® Test, the only blood test that accurately identifies an individual patient’s risk for aggressive prostate cancer. This important event upgrades the 4Kscore Test from a Category III Administrative code to a […]
MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NYSE:OPK) today announced that it has entered into agreements with Stratose, Three Rivers Provider Network and Fortified Provider Network for testing services from OPKO Lab, including the 4Kscore®Test, the only blood test that accurately identifies an individual patient’s risk for high-grade, aggressive cancer. The cumulative contracts, with some of the largest healthcare PPO network […]
PR Newswire Transaction to enhance Labcorp’s laboratory services network and expand access to the company’s high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI, March 28, 2024 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select […]
OPKO Press Release MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, today announced that Jon R. Cohen, M.D., is retiring from his role as Executive Chairman and Chief Executive Officer of BioReference Laboratories and Senior Vice President and a Director of OPKO. He will remain as […]
19
Jul
Jul
July is UV Safety Month – an excellent reminder to protect your skin from ultraviolet (UV) rays that can cause skin cancer.1 Sun safety is important year-round, but it’s especially essential in the summer when UV rays reach peak strength across the continental U.S.2 For UV Safety Month, we’re highlighting some information about skin cancer […]
04
May
May
Along with warmer weather and blooming flowers, the month of May brings Asthma and Allergy Awareness Month – a time to draw attention to these conditions and how they can intersect. More than 25 million people in the United States have asthma, according to the Asthma and Allergy Foundation of America (AAFA), and allergic asthma […]
19
Jan
Jan
According to the American Thyroid Association (ATA), more than 12 percent of the United States population will develop a thyroid condition during their lifetime. Although most thyroid diseases are life-long conditions, the ATA advises that they can be managed with medical attention.1 Thyroid Awareness | Get to Know the Gland This January, observe Thyroid Awareness […]
13
Dec
Dec
This December, BioReference is proud to be celebrating an exciting milestone – our 40th anniversary. For over four decades, our dedicated team has worked to build a legacy of scientific expertise through innovative and tailored laboratory test solutions. Join us in celebrating our 40th anniversary and learn more about our dynamic evolution. BioReference Celebrates 40 […]
